Genome Institute of Singapore, OBD Collaborate on Stem Cell Epigenetic Signatures | GenomeWeb

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore today announced an agreement with Oxford Biodynamics to identify epigenetic signatures in stem cells.

The collaboration leverages OBD's EpiSwitch biomarker discovery platform, which allows researchers to discover and monitor highly specific epigenetic biomarkers called chromosome conformation signatures. These biomarkers define and control important elements of epigenetic and gene regulation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.